Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
North America (Primary) | PRIMARYNOAM | Univ | 8,182 | 57,735,260 | 1.17% | 0.69% | -0.55% | 3.20% | 17.21% | 22.70% |
Healthcare | HEALTHCARE | Sector | 1,343 | 6,388,469 | 0.29% | 1.41% | -0.56% | -1.12% | 15.27% | 9.49% |
Biopharmaceuticals | BIOPHARMA | SubSec | 680 | 2,955,318 | 0.10% | 2.57% | -1.73% | -2.72% | 23.89% | 24.55% |
System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 308 | 1,511,979 | -0.59% | 2.10% | -2.46% | -2.28% | 20.73% | 10.62% |
Dermatology Biopharmaceuticals | DERMATOLOGY | SubInd | 25 | 22,465 | 1.07% | 4.66% | -5.27% | 7.75% | 38.84% | 9.99% |
Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
Taro Pharmaceutical Industries Ltd. | TARO:USATARO:USA | Stock | 1 | 1,595 | -0.14% | 0.12% | 0.76% | -0.07% | 21.01% | 61.22% |
S&P 500 | SPY:USASPY:USA | Benchmark | 14,779 | 75,176,635 | 1.24% | 0.60% | -0.35% | 4.13% | 19.55% | 28.03% |
Evolus, Inc. | EOLS:USAEOLS:USA | Stock | 1 | 769 | 0.61% | 16.36% | -0.89% | 4.15% | 70.95% | 60.05% |
Roivant Sciences Ltd. | ROIV:USAROIV:USA | Stock | 1 | 9,168 | 1.33% | 3.26% | -1.04% | 13.67% | 25.72% | 35.60% |
Dermatology Biopharmaceuticals | DERMATOLOGY | SubInd | 25 | 22,465 | 1.07% | 4.66% | -5.27% | 7.75% | 38.84% | 9.99% |
Protagonist Therapeutics, Inc. | PTGX:USAPTGX:USA | Stock | 1 | 1,506 | 2.15% | 3.74% | -5.64% | 0.31% | 69.31% | 10.55% |
Apogee Therapeutics, Inc. | APGE:USAAPGE:USA | Stock | 1 | 2,745 | 3.81% | 14.98% | -8.15% | 50.53% | 191.50% | N/A |
Krystal Biotech, Inc. | KRYS:USAKRYS:USA | Stock | 1 | 4,549 | 0.54% | 2.69% | -9.74% | 44.02% | 35.32% | 96.03% |
Arcutis Biotherapeutics, Inc. | ARQT:USAARQT:USA | Stock | 1 | 774 | -6.98% | -5.55% | -25.58% | 32.89% | 260.36% | -44.75% |
* Colors indicate performance relative to the benchmark.